Disease progression and neuroscience

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.40, Iss.3, 2013-06, pp. : 369-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Progression of Parkinson's Disease

Current Neuropharmacology, Vol. 7, Iss. 1, 2009-03 ,pp. : 9-36

Bentham Science Publishers

Access to resources Recommend Favorite

Anger, hostility and progression of arteriosclerotic disease

By Kaplan G.A. Salonen J.T. Julkunen J. Kauhanen J. Salonen R.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 221-221

Elsevier

Access to resources Recommend Favorite

Levodopa/carbidopa and Parkinson's disease progression

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Slowing progression in Alzheimer's disease: potential of `Cerebrolysin'

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite